{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T05:55:24Z","timestamp":1771048524905,"version":"3.50.1"},"reference-count":55,"publisher":"Elsevier BV","issue":"31","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T00:00:00Z","timestamp":1686787200000},"content-version":"vor","delay-in-days":349,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.vaccine.2022.05.063","type":"journal-article","created":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T08:04:12Z","timestamp":1654157052000},"page":"4105-4115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Evaluation of prime and prime-boost immunization strategies in BALB\/c mice inoculated with Leishmania infantum transfected with toxic plasmids"],"prefix":"10.1016","volume":"40","author":[{"given":"Guilherme","family":"Augusto Sanches Roque","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nahiara","family":"Esteves Zorgi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisca","family":"Jana\u00edna Soares Rocha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Fl\u00f3ro e Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thalita","family":"Fernanda Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Ruiz Ab\u00e1nades","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Selma","family":"Giorgio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2022.05.063_b0005","doi-asserted-by":"crossref","unstructured":"Torres-Guerrero, E.; Quintanilla-Cedillo, M.R.; Ruiz-Esmenjaud, J.; Arenas, R. Leishmaniasis: A Review. F1000Research 2017, 6, 750, doi:10.12688\/f1000research.11120.1.","DOI":"10.12688\/f1000research.11120.1"},{"key":"10.1016\/j.vaccine.2022.05.063_b0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035671","article-title":"the WHO Leishmaniasis Control Team Leishmaniasis Worldwide and Global Estimates of Its Incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2022.05.063_b0015","unstructured":"Leishmaniasis Available online: https:\/\/www.who.int\/westernpacific\/health-topics\/leishmaniasis (accessed on 5 January 2022)."},{"key":"10.1016\/j.vaccine.2022.05.063_b0020","unstructured":"Manual de vigil\u00e2ncia da leishmaniose tegumentar [eletronic resource]. 191."},{"key":"10.1016\/j.vaccine.2022.05.063_b0025","doi-asserted-by":"crossref","first-page":"6697","DOI":"10.1128\/IAI.70.12.6697-6706.2002","article-title":"Characterization of Leishmania donovani Antigens Encapsulated in Liposomes That Induce Protective Immunity in BALB\/c Mice","volume":"70","author":"Afrin","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2022.05.063_b0030","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1007\/s11096-011-9544-8","article-title":"A Rare Case of Visceral Leishmaniasis with Multiple Relapse and Multi-Drug Unresponsive: Successfully Treated with Combination Therapy","volume":"33","author":"Kumar","year":"2011","journal-title":"Int. J. Clin. Pharm."},{"issue":"1","key":"10.1016\/j.vaccine.2022.05.063_b0035","article-title":"A Second Generation Leishmanization Vaccine with a Markerless Attenuated Leishmania major Strain Using CRISPR Gene Editing","volume":"11","author":"Zhang","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.vaccine.2022.05.063_b0040","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.molimm.2020.08.006","article-title":"Leishmania infantum Transfected with Toxic Plasmid Induces Protection in Mice Infected with Wild Type L. infantum or L. amazonensis","volume":"127","author":"Zorgi","year":"2020","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.vaccine.2022.05.063_b0045","doi-asserted-by":"crossref","first-page":"B244","DOI":"10.1016\/j.vaccine.2012.11.080","article-title":"Case Study for a Vaccine against Leishmaniasis","volume":"31","author":"Alvar","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.05.063_b0050","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1016\/j.vaccine.2015.12.071","article-title":"Status of Vaccine Research and Development of Vaccines for Leishmaniasis","volume":"34","author":"Gillespie","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.05.063_b0055","doi-asserted-by":"crossref","first-page":"3895","DOI":"10.1016\/j.vaccine.2014.05.009","article-title":"Generation of Growth Arrested Leishmania Amastigotes: a Tool to Develop Live Attenuated Vaccine Candidates against Visceral Leishmaniasis","volume":"32","author":"Selvapandiyan","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.05.063_b0060","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.4049\/jimmunol.1500752","article-title":"Cutaneous Infection with Leishmania major Mediates Heterologous Protection against Visceral Infection with Leishmania infantum","volume":"195","author":"Romano","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.vaccine.2022.05.063_b0065","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.639801","article-title":"Revival of Leishmanization and Leishmanin","volume":"11","author":"Pacheco-Fernandez","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.vaccine.2022.05.063_b0070","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.0105-2896.2004.00190.x","article-title":"Does the Leishmania major Paradigm of Pathogenesis and Protection Hold for New World Cutaneous Leishmaniases or the Visceral Disease?","volume":"201","author":"McMahon-Pratt","year":"2004","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.vaccine.2022.05.063_b0075","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00005-008-0010-9","article-title":"Live Attenuated Leishmania Vaccines: a Potential Strategic Alternative","volume":"56","author":"Silvestre","year":"2008","journal-title":"Arch. Immunol. Ther. Exp. (Warsz.)"},{"key":"10.1016\/j.vaccine.2022.05.063_b0080","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3389\/fimmu.2014.00134","article-title":"Live Vaccination Tactics: Possible Approaches for Controlling Visceral Leishmaniasis","volume":"5","author":"Saljoughian","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.vaccine.2022.05.063_b0085","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1016\/j.vaccine.2019.04.068","article-title":"Leishmania major P27 Gene Knockout as a Novel Live Attenuated Vaccine Candidate: Protective Immunity and Efficacy Evaluation against Cutaneous and Visceral Leishmaniasis in BALB\/c Mice","volume":"37","author":"Elikaee","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.05.063_b0090","doi-asserted-by":"crossref","first-page":"196.29","DOI":"10.4049\/jimmunol.202.Supp.196.29","article-title":"Immunization with Leishmania major Centrin Knock-out (LmCen\u2212\/\u2212) Parasites Induces Skin Resident Memory T Cells That Plays a Role in Protection against Wild Type Infection (LmWT)","volume":"202","author":"Ismail","year":"2019","journal-title":"J. Immunol."},{"key":"10.1016\/j.vaccine.2022.05.063_b0095","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0166-6851(00)00290-5","article-title":"A New Developmentally Regulated Gene Family in Leishmania Amastigotes Encoding a Homolog of Amastin Surface Proteins","volume":"110","author":"Wu","year":"2000","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.vaccine.2022.05.063_b0100","series-title":"Life-cycle Dependent Gene Expression Plasmid for Leishmania. Phd thesis in Pathology, Federal University of Bahia. Medical Faculty from Bahia","author":"Arruda","year":"2013"},{"key":"10.1016\/j.vaccine.2022.05.063_b0105","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1128\/AEM.69.2.1108-1113.2003","article-title":"A Single Mutation in the Activation Site of Bovine Trypsinogen Enhances Its Accumulation in the Fermentation Broth of the Yeast Pichiap pastoris","volume":"69","author":"Hanquier","year":"2003","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.vaccine.2022.05.063_b0110","unstructured":"Chopra, A. Avidin-Gadolinium. In Molecular Imaging and Contrast Agent Database (MICAD); National Center for Biotechnology Information (US): Bethesda (MD), 2004."},{"key":"10.1016\/j.vaccine.2022.05.063_b0115","doi-asserted-by":"crossref","first-page":"320","DOI":"10.6026\/97320630005320","article-title":"A Gp63 Based Vaccine Candidate against Visceral Leishmaniasis","volume":"5","author":"Sinha","year":"2011","journal-title":"Bioinformation"},{"key":"10.1016\/j.vaccine.2022.05.063_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.cimid.2020.101551","article-title":"Phenotype Evaluation of Human and Canine Isolates of Leishmania infantum","volume":"73","author":"Ara\u00fajo","year":"2020","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"key":"10.1016\/j.vaccine.2022.05.063_b0125","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1471-2199-10-48","article-title":"Key Role of the 3\u2019 Untranslated Region in the Cell Cycle Regulated Expression of the Leishmania infantum Histone H2A Genes: Minor Synergistic Effect of the 5\u2019 Untranslated Region","volume":"10","author":"Abanades","year":"2009","journal-title":"BMC Mol. Biol."},{"key":"10.1016\/j.vaccine.2022.05.063_b0130","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1128\/AAC.39.9.2167","article-title":"Culture Microtitration: A Sensitive Method for Quantifying Leishmania infantum in Tissues of Infected Mice","volume":"39","author":"Buffet","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"issue":"10","key":"10.1016\/j.vaccine.2022.05.063_b0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004179","article-title":"Cytokine release assays as tests for exposure to Leishmania, and for confirming cure from leishmaniasis, in solid organ transplant recipients","volume":"9","author":"Carrillo","year":"2015","journal-title":"PLoS neglected tropical diseases"},{"key":"10.1016\/j.vaccine.2022.05.063_b0140","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2019.02268","article-title":"Relationship of Serum Antileishmanial Antibody With Development of Visceral Leishmaniasis, Post-Kala-Azar Dermal Leishmaniasis and Visceral Leishmaniasis Relapse","volume":"10","author":"Mondal","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.vaccine.2022.05.063_b0145","first-page":"245","article-title":"Immune Responses in Kala-Azar","volume":"123","author":"Saha","year":"2006","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.vaccine.2022.05.063_b0150","doi-asserted-by":"crossref","DOI":"10.1111\/pim.12732","article-title":"Genetically Modified Live Attenuated Vaccine: A Potential Strategy to Combat Visceral Leishmaniasis","volume":"42","author":"Pandey","year":"2020","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.vaccine.2022.05.063_b0155","doi-asserted-by":"crossref","first-page":"380","DOI":"10.3389\/fimmu.2014.00380","article-title":"Visceral Leishmaniasis: Advancements in Vaccine Development via Classical and Molecular Approaches","volume":"5","author":"Joshi","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.vaccine.2022.05.063_b0160","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1128\/cdli.4.5.530-535.1997","article-title":"Antibody Response against a Leishmania donovani Amastigote-Stage-Specific Protein in Patients with Visceral Leishmaniasis","volume":"4","author":"Ghedin","year":"1997","journal-title":"Clin. Diagn. Lab. Immunol."},{"issue":"2","key":"10.1016\/j.vaccine.2022.05.063_b0165","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3390\/pathogens9020079","article-title":"Suicidal Leishmania","volume":"9","author":"Pode\u0161vov\u00e1","year":"2020","journal-title":"Suicidal Leishmania. Pathogens"},{"key":"10.1016\/j.vaccine.2022.05.063_b0170","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/eji.200838389","article-title":"Photodynamic Vaccination of Hamsters with Inducible Suicidal Mutants of Leishmania amazonensis Elicits Immunity against Visceral Leishmaniasis","volume":"39","author":"Kumari","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.vaccine.2022.05.063_b0175","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.0105-2896.2004.00188.x","article-title":"The Immunopathology of Experimental Visceral Leishmaniasis","volume":"201","author":"Kaye","year":"2004","journal-title":"Immunol. Rev."},{"issue":"1","key":"10.1016\/j.vaccine.2022.05.063_b0180","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ddmod.2004.07.005","article-title":"Animal Models for Infectious Diseases Caused by Parasites: Leishmaniasis","volume":"1","author":"Oliveira","year":"2004","journal-title":"Drug Discov. Today Dis. Models"},{"key":"10.1016\/j.vaccine.2022.05.063_b0185","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.actatropica.2003.09.010","article-title":"Influence of the Inoculation Route in BALB\/c Mice Infected by Leishmania infantum","volume":"90","author":"Rol\u00e3o","year":"2004","journal-title":"Acta Trop."},{"key":"10.1016\/j.vaccine.2022.05.063_b0190","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/1756-3305-4-150","article-title":"Leishmania infantum HSP70-II null mutant as candidate vaccine against leishmaniasis: a preliminary evaluation","volume":"4","author":"Carri\u00f3n","year":"2011","journal-title":"Parasit Vectors."},{"key":"10.1016\/j.vaccine.2022.05.063_b0195","article-title":"Phenotypical Characterization of Spleen Remodeling in Murine Experimental Visceral Leishmaniasis","volume":"11","author":"Melo","year":"202011653","journal-title":"Front Immunol."},{"issue":"12","key":"10.1016\/j.vaccine.2022.05.063_b0200","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1093\/cid\/ciy811","article-title":"Asymptomatic visceral Leishmania infantum infection in US soldiers deployed to Iraq","volume":"68","author":"Mody","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.vaccine.2022.05.063_b0205","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1093\/cid\/ciu102","article-title":"Asymptomatic Leishmania Infection: A New Challenge for Leishmania Control","volume":"58","author":"Singh","year":"2014","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am."},{"issue":"1","key":"10.1016\/j.vaccine.2022.05.063_b0210","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.bbrc.2010.03.144","article-title":"A prime-boost vaccination strategy using attenuated Salmonella typhimurium and a replication-deficient recombinant adenovirus vector elicits protective immunity against human respiratory syncytial virus","volume":"395","author":"Fu","year":"2010","journal-title":"Biochem Biophys Res Commun."},{"issue":"4","key":"10.1016\/j.vaccine.2022.05.063_b0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002174","article-title":"Development of novel prime-boost strategies based on a tri-gene fusion recombinant L. tarentolae vaccine against experimental murine visceral leishmaniasis","volume":"7","author":"Saljoughian","year":"2013","journal-title":"PLoS neglected tropical diseases"},{"issue":"1","key":"10.1016\/j.vaccine.2022.05.063_b0220","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-30076-7","article-title":"Growth arrested live-attenuated Leishmania infantum KHARON1 null mutants display cytokinesis defect and protective immunity in mice","volume":"8","author":"Santi","year":"2018","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.vaccine.2022.05.063_b0225","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12917-017-0960-4","article-title":"Homologous prime-boost immunization with live attenuated Salmonella enterica serovar Senftenberg and its preventive efficacy against experimental challenge with various strains of S","volume":"13","author":"Kamble","year":"2017","journal-title":"Senftenberg. BMC Vet Res."},{"key":"10.1016\/j.vaccine.2022.05.063_b0230","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-3024.2006.00817.x","article-title":"Immunohistological Features of Visceral Leishmaniasis in BALB\/c Mice","volume":"28","author":"Carri\u00f3n","year":"2006","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.vaccine.2022.05.063_b0235","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1297-9716-42-39","article-title":"Mechanisms of Resistance and Susceptibility to Experimental Visceral Leishmaniosis: BALB\/c Mouse versus Syrian Hamster Model","volume":"42","author":"Nieto","year":"2011","journal-title":"Vet. Res."},{"issue":"4","key":"10.1016\/j.vaccine.2022.05.063_b0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006445","article-title":"Morphophysiological changes in the splenic extracellular matrix of Leishmania infantum-naturally infected dogs is associated with alterations in lymphoid niches and the CD4+ T cell frequency in spleens","volume":"12","author":"da Silva","year":"2018","journal-title":"PLoS neglected tropical diseases"},{"key":"10.1016\/j.vaccine.2022.05.063_b0245","first-page":"323","article-title":"Structural and Ultrastructural Hepatic Changes in Experimental Canine Leishmaniasis","volume":"3","author":"Gonz\u00e1lez","year":"1988","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.vaccine.2022.05.063_b0250","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.mehy.2004.08.028","article-title":"Swelling of Hepatocytes Injured by Oxidative Stress Suggests Pathological Changes Related to Macromolecular Crowding","volume":"64","author":"Del Monte","year":"2005","journal-title":"Med. Hypotheses"},{"issue":"2","key":"10.1016\/j.vaccine.2022.05.063_b0255","article-title":"Asymptomatic leishmaniasis in kala-azar endemic areas of Malda district, West Bengal","volume":"11","author":"Saha","year":"2017","journal-title":"India. PLoS neglected tropical diseases"},{"issue":"1","key":"10.1016\/j.vaccine.2022.05.063_b0260","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1146\/annurev.iy.08.040190.001511","article-title":"Lymphokine Control of In Vivo Immunoglobulin Isotype Selection","volume":"8","author":"Finkelman","year":"1990","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.vaccine.2022.05.063_b0265","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1574-695X.2007.00311.x","article-title":"Immune Response to Leishmania: Paradox Rather than Paradigm","volume":"51","author":"Tripathi","year":"2007","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.vaccine.2022.05.063_b0270","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0264-410X(01)00322-X","article-title":"Immunization with A2 Protein Results in a Mixed Th1\/Th2 and a Humoral Response Which Protects Mice against Leishmania donovani Infections","volume":"20","author":"Ghosh","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.05.063_b0275","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.vaccine.2003.09.030","article-title":"A Mixed Th1\/Th2 Response Elicited by a Liposomal Formulation of Leishmania Vaccine Instructs Th1 Responses and Resistance to Leishmania donovani in Susceptible BALB\/c Mice","volume":"22","author":"Mazumdar","year":"2004","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22006818?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22006818?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:13:47Z","timestamp":1759403627000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22006818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":55,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S0264410X22006818"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.05.063","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of prime and prime-boost immunization strategies in BALB\/c mice inoculated with Leishmania infantum transfected with toxic plasmids","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.05.063","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}